Leading A Research Revolution

Max Wallace, CEO of Accelerate Brain Cancer Cure, shares our collaborative, venture-funding approach that drives cutting-edge brain tumor research and treatments.

Share |
June 17, 2015 09:46 AM
These studies provide a foundational rationale for ABC2's efforts in the profiling space.
June 4, 2015 01:18 PM
An ABC2-funded brain cancer vaccine receives positive reviews at the American Society of Clinical Oncology annual meeting.
May 31, 2015 01:58 PM
Our deepest sympathies go out to his friends and family. 

Join us in our fight for a cure!